Moreover, global proteome analysis revealed that, compared to CRC cells with WT KRAS, cells with KRASG12D or KRASG13D were enriched in pathways related to the cell cycle, DNA replication, and proteoglycans [24]. This evidence concerns the gene KRAS and colorectal carcinoma.